Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

A High-Throughput Dose-Response Cellular Thermal Shift Assay for Rapid Screening of Drug Target Engagement in Living Cells, Exemplified Using SMYD3 and IDO1.

McNulty DE, Bonnette WG, Qi H, Wang L, Ho TF, Waszkiewicz A, Kallal LA, Nagarajan RP, Stern M, Quinn AM, Creasy CL, Su DS, Graves AP, Annan RS, Sweitzer SM, Holbert MA.

SLAS Discov. 2018 Jan;23(1):34-46. doi: 10.1177/2472555217732014. Epub 2017 Sep 28.

PMID:
28957646
2.

On Old-Fashioned Versus Modern Homonegativity Distinction: Evidence From Poland.

Górska P, Bilewicz M, Winiewski M, Waszkiewicz A.

J Homosex. 2017;64(2):256-272. Epub 2016 Apr 19.

PMID:
27093374
3.

Dexamethasone-dependent modulation of cyclic GMP synthesis in podocytes.

Lewko B, Waszkiewicz A, Maryn A, Gołos M, Latawiec E, Daca A, Witkowski JM, Angielski S, Stępiński J.

Mol Cell Biochem. 2015 Nov;409(1-2):243-53. doi: 10.1007/s11010-015-2528-6. Epub 2015 Aug 14.

4.

The discovery of potent blockers of the canonical transient receptor channels, TRPC3 and TRPC6, based on an anilino-thiazole pharmacophore.

Washburn DG, Holt DA, Dodson J, McAtee JJ, Terrell LR, Barton L, Manns S, Waszkiewicz A, Pritchard C, Gillie DJ, Morrow DM, Davenport EA, Lozinskaya IM, Guss J, Basilla JB, Negron LK, Klein M, Willette RN, Fries RE, Jensen TC, Xu X, Schnackenberg CG, Marino JP Jr.

Bioorg Med Chem Lett. 2013 Sep 1;23(17):4979-84. doi: 10.1016/j.bmcl.2013.06.047. Epub 2013 Jun 26.

PMID:
23886683
5.

An orally active TRPV4 channel blocker prevents and resolves pulmonary edema induced by heart failure.

Thorneloe KS, Cheung M, Bao W, Alsaid H, Lenhard S, Jian MY, Costell M, Maniscalco-Hauk K, Krawiec JA, Olzinski A, Gordon E, Lozinskaya I, Elefante L, Qin P, Matasic DS, James C, Tunstead J, Donovan B, Kallal L, Waszkiewicz A, Vaidya K, Davenport EA, Larkin J, Burgert M, Casillas LN, Marquis RW, Ye G, Eidam HS, Goodman KB, Toomey JR, Roethke TJ, Jucker BM, Schnackenberg CG, Townsley MI, Lepore JJ, Willette RN.

Sci Transl Med. 2012 Nov 7;4(159):159ra148. doi: 10.1126/scitranslmed.3004276.

6.

[Studies of some penicillinates of beta-hydroxyethylpiperazine-methyltetracycline].

Sobiczewski W, Waszkiewicz A, Styczyńska D.

Acta Pol Pharm. 1969;6(1):33-8. Polish. No abstract available.

PMID:
5787581
7.

[Derivatives of viomycin. V. Di(oxytetracyclinemethyl)viomycin and tri(oxytetracyclinemethyl)viomycin, preparation and properties].

Sobiczewski W, Cieślak J, Chojnowski W, Waszkiewicz A.

Acta Pol Pharm. 1969;26(3):237-40. Polish. No abstract available.

PMID:
4308291
8.

[Viomycin derivatives. IV. Preparation and properties of some penicillinates].

Sobiczewski W, Cieślak J, Chojnowski W, Waszkiewicz A, Cendrowska H.

Acta Pol Pharm. 1969;26(1):29-32. Polish. No abstract available.

PMID:
4305691
9.

[Derivatives of viomycin. 3. Viomycin-methyltetracyclines, their preparation and properties].

Sobiczewski W, Chojnowski W, Waszkiewicz A.

Acta Pol Pharm. 1968;25(6):563-7. Polish. No abstract available.

PMID:
4307876
10.

[Derivatives of viomycin. II. Preparation and properties of some viomycin penicillinates].

Sobiczewski W, Cieślak J, Chojnowski W, Waszkiewicz A, Cendrowska H.

Acta Pol Pharm. 1968;25(4):407-10. Polish. No abstract available.

PMID:
4299476
11.

[Derivatives of viomycin. I. Preparation and properties of viomycin nicotinate and isonicotinate].

Sobiczewski W, Cieślak J, Waszkiewicz A, Chojnowski W.

Acta Pol Pharm. 1968;25(4):403-5. Polish. No abstract available.

PMID:
4299475

Supplemental Content

Loading ...
Support Center